- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Diabetic kidney disease
- Meeting Date: July 2022
- Public Summary Document (PSD) July 2022 PBAC Meeting - (PDF 885KB)
- Public Summary Document (PSD) July 2022 PBAC Meeting - (Word 161KB)
Finerenone – July 2022
Finerenone: Tablet 10 mg, Tablet 20 mg; Kerendia®
Last updated
11 November 2022